The QualityStocks Daily Thursday, April 19th, 2018

Today's Top 3 Investment Newsletters

MarketClub Analysis (HWVI) +462.50%

Penny Picks (TWOH) +71.93%

CannabisNewsWire (GOHE) +32.93%

The QualityStocks Daily Stock List

Golden Arrow Resources Corp. (GARWF)

Money and Markets and FutureMoneyTrends reported earlier on Golden Arrow Resources Corp. (GARWF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Golden Arrow Resources Corp. is an explorer and prospect generator. The Company’s focus is on identifying, acquiring, and advancing precious and base metal discoveries with the objective of defining first-class deposits. Its main emphasis is on advancing its flagship Chinchillas Silver Project in Jujuy Province, Argentina. Golden Arrow Resources is a member of the Grosso Group; a management company specializing in resource exploration. Golden Arrow Resources has exploration offices in Ciudad de Mendoza, Argentina.

The Company’s other Argentina projects include the Antofalla Silver-Gold-Base Metal Project in Catamarca Province; and the Don Bosco Copper-Gold Project and the Caballos Copper-Gold Project, both in La Rioja Province.

Additionally, projects include the Mogote Copper-Gold Project; the Pescado Gold Project; and the Frontera District - Potrerillos Gold-Silver Project. All of these projects are in San Juan Province.

The Chinchillas Silver deposit will be developed into a satellite open-pit mine. The Chinchillas Silver Project features low capex (capital expenditure) and fast-tracked development utilizing infrastructure from the Pirquitas mine. It has a positive pre-feasibility study with strong economics and immediate production income from the Pirquitas mine operation.

Golden Arrow Resources formed a Joint Venture (JV) with Silver Standard Resources, Inc. announced on May 31, 2017. This JV is called Puna Operations, Inc. (POI). It was created to hold the Chinchillas project and the Pirquitas project, which consists of the San Miguel open pit mine that ended mining operations in January 2017 (the Pirquitas Pit), and the associated mineral processing facilities and tailings facility (the Pirquitas Operation) in Argentina. POI is 75 percent owned and operated by Silver Standard, and owned 25 percent by Golden Arrow Resources.

Puna Operations has received approval of the Environmental Impact Assessment (EIA) that allows for the exploitation of the Chinchillas silver lead zinc deposit in Jujuy Province, Argentina. This paves the way for expected delivery of first ore from Chinchillas to the Pirquitas mill in the second half of this year, eventually reaching planned life of mine annual average production of 8.4M ounces silver equivalent. Golden Arrow Resources has also formed a 100 percent owned subsidiary named “New Golden Explorations, Inc.” This subsidiary will seek a listing on the stock exchange to access funding for future exploration. Golden Arrow’s intention is to initially give up 40 percent and retain a 60 percent carried interest on new discovery values.

At present, New Golden Explorations is exploring. It plans on drilling three very advanced prospects to realize new discoveries. Exploration restarted on all the projects on January 7, 2018. This created a second value stream for shareholders of Golden Arrow.

Last month, Golden Arrow Resources announced that it started the first diamond drill program at the Antofalla silver-gold-base metal project in Catamarca Province, Argentina. The program is planned to include up to 3,000 meters of drilling on numerous targets, which were delineated in the 2017 surface exploration and trenching programs.

Golden Arrow Resources Corp. (GARWF), closed Friday's trading session at $0.4288, down 0.28%, on 158,645 volume with 55 trades. The average volume for the last 60 days is 87,100 and the stock's 52-week low/high is $0.2904/$0.5799.

HD View 360, Inc. (HDVW)

TradingView, OTC Markets, MarketWatch, and MarketNewsUpdates reported on HD View 360, Inc. (HDVW), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

HD View 360, Inc. and its subsidiary companies are a complete Business-to-Business (B2B) Information Technology solution. The Company provides hardware installation, security monitoring systems, telephone services, merchant processing, Point-of-Sale (POS) software, and continuing Information Technology (IT) support to small and medium-sized businesses (SMBs).

A full-service IT company, HD View 360 has practical experience in almost all aspects of retail operations. HD View 360 has its corporate office in Miami, Florida. The Company’s shares trade on the OTC Markets.

One of the Company’s wholly-owned subsidiaries is SimpleFone. This subsidiary is a unique Voice over Internet Protocol (VoIP) provider. At present, SimpleFone is selling its telephone services to many nationally-recognized franchise brands. HD View 360 is positioning SimpleFone to become a top VoIP carrier.

In September of 2017, HD View 360 and Voice Solutions, Inc. announced a new strategic partnership. The partnership will leverage access to enterprise-level customers and create mutual avenues of recurring revenue streams for both businesses. Voice Solutions is one of the leading providers of in-store music, on-hold message services, digital signage, sound masking, and other impactful sensory marketing services.

Previously, HD View 360 announced the launch of development of its proprietary POS Software via its wholly-owned subsidiary, HD View Technologies. The specific design of this POS solution is with the franchise and multi-location retail segment in mind. The POS solution will seamlessly integrate its clients’ businesses, products, customers, and payment systems into one user-friendly platform.

Subsidiary HD View Technologies earlier signed its first Letter of Intent (LOI) with Pizzafire. This is to supply its POS technology to all locations throughout the country. HD View 360 announced in November of 2017 the completion of an extensive IT installation at a Pizzafire location in Fort Lauderdale, Florida.

Recently, HD View 360 announced it is in a number of talks to explore and implement Blockchain Technology enhancements to its wholly-owned subsidiary, SimpleFone. Through Providing Blockchain technology to its already secure platform, the Company’s B2B and B2C customers will be able to totally accept and process secure transactions anonymously. SimpleFone’s new VoIP encrypted phone switch can service up to 100,000 phone lines at the same time.

Mr. Dennis Mancino, HD View 360’s Chief Executive Officer, said this past February, "As we gain traction through our discussions, we are looking forward to introducing block chain technology to our B2B and B2C SimpleFone clients in the near future. We are having several discussions with Blockchain Technology Companies that would work side by side with us in developing and implementing this for SimpleFone's platform."

HD View 360, Inc. (HDVW), closed Friday's trading session at $0.06, even for the day. The average volume for the last 60 days is 33,204 and the stock's 52-week low/high is $0.01/$5.65.

OriginClear, Inc. (OCLN)

MarketWatch reported on OriginClear, Inc. (OCLN), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, OriginClear, Inc. is a leading provider of water treatment solutions. The Company is also the developer of an inventive water cleanup technology. By way of its wholly-owned subsidiaries, OriginClear provides systems and services to treat water in a broad assortment of industries. These include municipal, pharmaceutical, semiconductors, industrial, and oil & gas. The Company has its wholly-owned subsidiary, Progressive Water Treatment (PWT) of Dallas, Texas. OriginClear has its head office in Los Angeles, California.

OriginClear invented Electro Water Separation™. This is a pioneering high-speed water cleanup technology employing multi-stage electrolysis, which OriginClear licenses globally to water treatment equipment manufacturers.

Electro Water Separation™ (EWS) is a highly scalable, continuous process. It uses electricity in small, programmed doses to gather up oils and suspended solids. Moreover, through Advanced Oxidation or AOx, it removes fine, micron-sized suspended solids, and dissolved contaminants, including ammonia.

OriginClear’s mission is to develop Electro Water Separation™ with Advanced Oxidation™ (EWS:AOx™) and accomplish its full recognition as an international industry standard in treating increasingly complex wastewater treatment challenges.

OriginClear entered into a Master Research Agreement with Florida Atlantic University (FAU) in Boca Raton, Florida. The Agreement establishes a cooperative framework for further scientific research and validation projects regarding the Company’s technology, Electro Water Separation with Advanced Oxidation (EWS:AOx), when applied to landfill leachate treatment.

This past October, OriginClear announced that its Asian subsidiary manufactured the Company's first standalone commercial system. This is a compact, full-duty commercial system that utilizes OriginClear's Advanced Oxidation Process, AOx™, to remove ammonia from high-salinity effluent from an electrode-plating facility. OriginClear deploys AOx by itself, when water is already free of suspended solids.

OriginClear Hong Kong is also manufacturing a lab-scale unit for a new licensee in Brazil. It recently built and delivered three like units for licensees in Spain, India and Thailand, and a larger-capacity research and development unit for a European project.

Last month, OriginClear announced a preliminary agreement with the National Superior Engineering School (ENSIL-ENSCI) of France's University of Limoges, to validate OriginClear's innovative process, Electro Water Separation with Advanced Oxidation™ (EWS:AOx™), for extremely challenging water treatment problems. The intellectual property (IP) and knowledge resulting from this collaboration will remain with OriginClear. This agreement followed OriginClear Technologies President Jean-Louis "JL" Kindler's presentation at the International IWA Conference in nearby Nantes.

OriginClear, Inc. (OCLN), closed Friday's trading session at $0.0353, up 7.62%, on 90,577 volume with 9 trades. The average volume for the last 60 days is 335,099 and the stock's 52-week low/high is $0.0099/$0.20.

CareView Communications, Inc. (CRVW)

Tiny Gems, PennyTrader Publisher, Wall Street Resources, BabyBulls, Stock Stars, MonsterStocksPick, FeedBlitz, Real Pennies, and MissionIR reported beforehand on CareView Communications, Inc. (CRVW), and today we report on the Company, here at the QualityStocks Daily Newsletter.

CareView Communications, Inc. is an Information Technology (IT) provider to the healthcare industry. It provides the next generation of patient care by way of its leading-edge data and patient monitoring system. This system connects patients, families, as well as healthcare professionals (the CareView System®). The CareView System can help a hospital lessen sitter costs, patient falls and injuries, manage patient flow, improve internal communications, and consolidate vendors. CareView Communications is headquartered in Lewisville, Texas.

CareView’s proprietary, high-speed data network system may be installed throughout a healthcare facility to provide the facility with recurring revenue and infrastructure for future applications. The CareView System allows for close observation of high-risk patients from manifold locations. The CareView Connect® mobile application provides patient monitoring and critical communication tools from an existing Wi-Fi Android or iOS device.

The CareView System is HIPAA-compliant (Health Insurance Portability and Accountability Act) and secure. The System does not record anything. In addition, it can include consent processes and privacy options. Concerning hospital benefits, the CareView System enables patients to watch first-run movies and access high-speed internet. The result of this is increased patient satisfaction.

The CareView System uses an infrared camera in patient rooms to deliver real-time visual monitoring around the clock. The Company installs its equipment in healthcare facilities at no charge. It subsequently produces revenue from subscriptions to its set of products and services. These are priced as a bundled service.

CareView Communications executed an agreement with Dish Network, LLC last year to become a Private Cable Operator (PCO). The agreement enables the Company to provide television network services through Dish Network as part of its complete set of products and services offered via its CareView System®.

CareView Communications’ cost effective platform and setup capitalizes on fixed cameras in the room. The system is username and password protected. It is accessible to qualified users on site only.

Recently, CareView Communications announced the launch of its CareView Connect Senior Care Quality of Life System™. This is a unique family of products and services, which improve the quality of life and safety of seniors who reside in independent and assisted living facilities, or who live alone at home. The CareView Connect Senior Care Quality of Life System™ comprises a small emergency assist button or pendant, passive motion sensors, bed sensors, and event sensors.

The CareView Connect System passively monitors a resident's daily activities. The System utilizes the collected data to establish the resident's norms within their living environment. After that, the CareView Connect System can notify family, staff and/or emergency responders of potential emergencies or when the resident deviates from those norms.

CareView Communications, Inc. (CRVW), closed Friday's trading session at $0.035, even for the day, on 5,000 volume with 1 trade. The average volume for the last 60 days is 79,197 and the stock's 52-week low/high is $0.02/$0.21.

Manhattan Scientifics, Inc. (MHTX)

SmallCapVoice, Hawk Associates, StockHotTips, BullRally, OurHotStockPicks, AllPennyStocks, Xtremepicks, The Penny Play, FeedBlitz, and HotStockChat reported previously on Manhattan Scientifics, Inc. (MHTX), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Manhattan Scientifics, Inc. focuses on the commercialization of disruptive technologies in the nano-medicine space. At present, it is developing commercial medical prosthetics applications for its ultra-fine grain metals. The Company’s aim is to commercialize the cancer research work and nano medical applications developed by Senior Scientific LLC, (now Imagion Biosystems) its wholly-owned subsidiary. Manhattan Scientifics has its head office in New York, New York. It also has an office in Albuquerque, New Mexico, and Montreal, Quebec.

Manhattan Scientifics is presently focusing on nanoparticle based cancer detection by way of Senior Scientific. It is also focusing on nanostructured metals technology through wholly-owned subsidiary Metallicum, Inc. Senior Scientific has established a research collaboration with Weill Cornell Medicine. For this alliance, it will bring its magnetic relaxometry technology to Weill Cornell Medicine. Scientists will investigate the use of molecularly targeted nanoparticles to non-invasively detect and diagnose prostate cancers.

Furthermore, Manhattan Scientifics is working on the start of product trials on its cancer detection product. The nanostructured metals technology has been revenue producing for some years. The cancer detection technology can detect cancer years earlier.

Manhattan Scientifics has expertise in licensing from the national laboratories (the Los Alamos National Laboratory (LANL) and the Sandia National Laboratory (SNL)). The Company also has expertise in working with individual inventors.

Manhattan Scientifics has an agreement to collaborate with The University of Texas M.D. Anderson Cancer Center (MDACC) to advance, demonstrate, and validate a pioneering technology developed by Mr. Edward R. Flynn, PhD, for the very early detection of cancer. The Company has delivered its innovative cancer measurement instrument to MDACC.

Manhattan Scientifics concentrates on technology transfer and commercialization of transformative technologies in the nano medicine space. It creates Intellectual Property (IP) portfolios and business cases supporting new technologies. The Company guides them to relationships with industrial partners who are well-prepared to launch product.

Manhattan Scientifics’ technology utilizes iron oxide nanoparticles and a technique it calls Magnetic Relaxometry to locate and measure cancers with a sensitivity that would provide a diagnosis years before other known methods.

Manhattan Scientifics incubated, spun out, and also IPO'd its Early Cancer Detection diagnostic (IBX.AX) following investments of approximately $30M including $7.5M from the N.I.H. and proceeds of its IPO (Initial Public Offering). Manhattan Scientifics owns 64 million IBX shares. It will consider dividending part or all of these to Manhattan Scientifics shareholders under certain circumstances.

Manhattan Scientifics, Inc. (MHTX), closed Friday's trading session at $0.015788, up 8.88%, on 52,265 volume with 3 trades. The average volume for the last 60 days is 206,062 and the stock's 52-week low/high is $0.011/$0.045.

Elcora Advanced Materials Corp. (ECORF)

InvestorIntel reported previously on Elcora Advanced Materials Corp. (ECORF), and we report on the Company today, here at the QualityStocks Daily Newsletter.

Elcora Advanced Materials Corp. has been designed to become a vertically integrated (from mine to product) graphite & graphene company, which mines, processes, refines graphite, and produces the graphene and end user graphene applications. The Company has developed a unique low cost-effective process to make high quality graphite and graphene that are commercially scalable. Elcora Advanced Materials is based in Bedford, Nova Scotia. The Company lists on the OTC Markets’ OTCQB.

Elcora Advanced Materials is targeting high-end graphite applications (Li-ion batteries, graphene production & coating). It acquired the full operational control and a 40 percent equity interest in Sakura Graphite (PVT) Limited, operators of the Ragedara mine in Sri Lanka. Sri Lanka graphite is very high quality with many unique properties. This graphite is suitable for use in numerous high-end graphite applications.

Elcora has secured high-grade graphite and graphene precursor graphite from its interest in the operation of the Ragedara mine in Sri Lanka. This mine is already in production. Currently, the mine yields about 500 tonnes each year.

The Company developed its own unique graphite refining process. The process does not require the use of acids or alkaline systems. Environmentally friendly, the process yields higher quality graphite that has not been oxidized and will withstand high temperatures.

Elcora announced in April 2017 that it is building a state-of-the-art Lithium Ion (Li-ion) battery research and development laboratory in Halifax, Nova Scotia. The lab will concentrate on quality control and developing the Company’s graphite anode powder for Li-ion batteries.

Graphite powder will be routinely tested employing industry standard cells. This is to ensure the coulombic efficiency, reversible capacity, first-cycle loss and rate capabilities of the product are within Elcora’s specifications.

Last month, Elcora Advanced Materials announced that it is working with a number of battery manufacturers in Asia that are testing the Company’s graphite anode powder. Elcora has so far sent more than14 kgs of its EL-I-C6 graphite anode powder to battery manufacturers to test its electrochemical performance.

The purpose of this testing is to demonstrate that the Company’s EL-I-C6 graphite anode powder meets Li-ion battery manufacturing standards. After more testing, Elcora Advanced Materials hopes to enter into negotiations for long-term supply agreements.

Moreover, in November, Elcora announced it signed a Memorandum of Understanding (MOU) agreement with Lockheed Martin Canada. This represents Lockheed Martin's first battery technology investment in Canada.

The strategic partnership supports the increasing energy demand for Lithium-Ion battery storage solutions applied to commercial, industrial, utility, and military applications. The MOU formally creates a working relationship and guidelines to support/identify opportunities within Lockheed Martin business units; including Lockheed’s energy division to help in maximizing and attaining sales goals.

Elcora Advanced Materials Corp. (ECORF), closed Friday's trading session at $0.271, up 2.38%, on 1,690 volume with 2 trades. The average volume for the last 60 days is 12,107 and the stock's 52-week low/high is $0.117/$0.439.

Lithium Exploration Group, Inc. (LEXG)

MicroCap Daily, Epic Stock Picks, OTC Markets, Insider Financial, Penny Stock Tweets, and The Wolf of Penny Stocks reported on Lithium Exploration Group, Inc. (LEXG), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

An exploration and development company, Lithium Exploration Group, Inc. centers on the acquisition and development potential of lithium brines and other precious metals, which demonstrate high probability for near-term production. At present, the Company is concentrating on sales and distribution of the Sonic Cavitation Ltd. technology as well as the acquisition of oil and gas related assets in the United States and Canada. Formed in 2006, Lithium Exploration is headquartered in Phoenix, Arizona.

The Company’s dedication is to developing assets and technologies in Oil & Gas, and Waste Treatment. It is developing an ultrasonic generator for diverse field applications in the oil and gas industry. The technology provides lower cost, low energy solutions to manifold pre-existing processes within these markets.

Lithium Exploration has partnered with Sonic Cavitation (SonCav) to develop SonCav's patented technology for the treatment of hydrocarbon fluid stocks and waste water. SonCav runs off of 3 phase electricity. It produces no on-site emissions.

The SonCav generator is skid mounted for easy mobility to even the most remote field locations. SonCav is currently field ready for customers throughout North America.

Lithium Exploration’s Oil & Gas assets comprise the White Top Field. This asset is situated onshore in Southwest Louisiana.  The cumulative production to-date is 32 million barrels. Present production is 120 barrels of oil per day.

At the beginning of March, Lithium Exploration announced that its partners in the White Top project are making significant progress on the preparations to close on the eventual acquisition of the field and development strategy. The seismic data has been completely processed. The Company states that it continues to impress all parties that have looked at it. Lithium Exploration has a royalty interest in the future development of the major oil and gas opportunity in Louisiana

The in-house geophysical team is drilling down on a series of shallow fault blocks that are visible in the data set and comparing them to historical production so as to finalize the development prioritization schedule.

Moreover, the Company’s Blockchain efforts in the oil and gas industry are moving ahead. However, Lithium Exploration is not spending any money on those efforts until after the completion of the royalty acquisition.  The Company is budgeting and getting all of the elements in place for that effort. It will look to partner with a couple of external companies to create the Blockchain marketplace that it will manage.

Lithium Exploration has been incubating a Blockchain concept that will make it considerably easier and more transparent for investors who are not part of the oil and gas ecosystem to participate in investment opportunities.

Lithium Exploration Group, Inc. (LEXG), closed Friday's trading session at $0.0193, even for the day, on 366,243 volume with 23 trades. The average volume for the last 60 days is 673,454 and the stock's 52-week low/high is $0.0003/$0.18.

SETO Holdings, Inc. (SETO)

Penny Stock Tweets, OTC Markets, 4-Traders, WalletInvestor, InvestorsHub, and Stockhouse reported on SETO Holdings, Inc. (SETO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A development stage company, SETO Holdings, Inc. provides healthcare services. Based in Hanover, Maryland, the Company focuses on three main sectors. These are Health, Education and Clean Energy.

SETO analyzes markets, operations, and guides businesses through the challenges they face. Regarding Healthcare, the Company provides hearing health care and distributes hearing aids via 15 hearing clinics in Maryland and Virginia. Established in 2004, SETO lists on the OTC Markets.

Advanced Hearing Group is the Company’s principal audiology and hearing Services Company. Advanced Hearing Group has clinics across the U.S. Mid-Atlantic region. Seto's Health (SH) division works to expand the Company’s other health services.

Seto Energy (SAE) promotes alternative energy projects in India. In addition, Seto's Education (SE) division promotes health education to the 50-plus active adult community Seto Life (SL).

SETO is working to expand its existing healthcare services within the U.S. The Company is pursuing the implementation of projects in developing markets, particularly in India. Concerning Clean Energy, SETO is expanding its operations to encompass clean energy in developing markets, again specifically in India.

In January of this year, SETO Holdings announced that its subsidiary entered the cannabis sector, specifically the $US15 billion medical marijuana sector. This represents a significant expansion within the Company's Health Division.

SETO’s plan is to execute Hydroponic farming techniques for the development of cannabis farming and for the development of products derived from medical marijuana cultivation. Additionally, the Company plans to implement financial technology solutions for the fast expanding, multi-billion-dollar cannabis sector.

Recently, SETO Holdings announced its newest hearing clinic in Frederick, Maryland. This clinic will center on pediatric and geriatric patients. This also boosts Seto Hearing Group's (SHG) presence in the market. SETO has partnered with the Department of Aging as the exclusive hearing care provider for its 20 facilities in Baltimore County, Maryland.

Last week, SETO Holdings announced it will start the development of medical software. This project is being developed under a subsidiary called Setosoft. Setosoft's software applications will augment the Company’s internal efficiencies and that of other healthcare providers. The design phase has been completed. Setosoft is putting together the team of software engineers to implement the project.”

SETO Holdings, Inc. (SETO), closed Friday's trading session at $0.10, even for the day. The average volume for the last 60 days is 41,704 and the stock's 52-week low/high is $0.007/$0.17.

Abattis Bioceuticals Corp. (ATTBF)

Stockgoodies, Cannabis Financial Network News, Greenbackers, PennyStocks24, Promotion Stock Secrets, InvestorIntel, CFN Media Group, Goldman Small Cap Research, and Information Solutions Group reported previously on Abattis Bioceuticals Corp. (ATTBF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Abattis Bioceuticals Corp. is a specialty, vertically-integrated biotechnology enterprise. The Company aggregates, incubates, integrates, and invests in the botanical drug development industry. Its divisions include Biocell Labs, Inc. and Vergence Sales & Marketing, Inc. By way of these, Abattis develops and licenses natural health products. The Company’s other divisions are Northern Vine Canada, Inc.; North American Bioextracts, Inc.; and Biocube Green Grow Systems Corp. OTCQB-listed, Abattis Bioceuticals is based in Vancouver, British Columbia.

The Company’s products and services include Botanical Blends & Formulas; CBD Ingredients; Functional Foods & Beverages; Research and Development (R&D); Analytical Services; and Pharma & Nutraceuticals. Abattis has received a Natural Product Number (NPN) approval for Phyto (NOS). This NPN allows it to manufacture and sell Phyto (NOS) in Canada.

Phyto (NOS) has applications in a wide spectrum of food, beverage, and nutraceutical products. Phyto (NOS) is an all-natural, patent-pending formulation. It naturally supports nitric oxide (a vasodilator) levels in the blood stream, supports nitric oxide production, and provides antioxidants.

Abattis Bioceuticals has capabilities that support the production and extraction of botanical ingredients for its products; one of which includes cannabis. The Company develops and licenses natural health products, medicines, extractions, and ingredients - some of which will contain cannabinoid compounds. In addition, Abattis has an extensive pipeline of high-quality products and intellectual property (IP) for the fast-developing botanical drug market.

Abattis Bioceuticals and Northern Vine entered into a Binding Memorandum of Agreement with Experion Biotechnologies to acquire up to 100 percent of Experion Biotechnologies, Inc. Abattis Management has been concentrating their efforts on its Northern Vine Lab buildout after receiving their controlled substance dealers license (CSL) in 2016. Northern Vine Labs has the required licenses and controls in place to legally possess and work with the raw herb (cannabis) and its active ingredients.

Recently, Abattis Bioceuticals announced it reached a definitive agreement with Global Damon Pharma (GD Pharma) of South Korea. This agreement is to distribute and sell Abattis’ product lines exclusively in South Korea. The agreement permits GD Pharma to commence sales of Abattis products in South Korea effective immediately. Abattis Bioceuticals and GD Pharma plan to work together on new formulations via Abattis’ subsidiary Northern Vine Canada.

In November, Abattis Bioceuticals announced the closing of its agreement with Emerald Health Therapeutics, Inc. Emerald has invested $2.5 million into Northern Vine Canada in exchange for a 53 percent equity stake in Northern Vine. Northern Vine has now received the $2.5 million investment. Abattis Bioceuticals remains a 47 percent equity stakeholder in Northern Vine.

Yesterday, Abattis Bioceuticals announced the successful completion of experiments confirming column chromatography extraction technology. These experiments measured the feasibility of applying the technology for the extraction of CBD, THC and THCA from industrial hemp and cannabis. Throughputs, yields, purity, as well as terpene profiles were also part of the range of work performed at its facility, Northern Vine Labs.

Abattis Bioceuticals Corp. (ATTBF), closed Friday's trading session at $0.174931, up 0.20%, on 832,600 volume with 194 trades. The average volume for the last 60 days is 1,327,725 and the stock's 52-week low/high is $0.0471/$0.7444.

InMed Pharmaceuticals, Inc. (IMLFF)

Promotion Stock Secrets and SmallCapVoice reported on InMed Pharmaceuticals, Inc. (IMLFF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

InMed Pharmaceuticals, Inc. is a fully integrated, cannabinoid-based biopharmaceutical company. It takes advantage of its proprietary bioinformatics and biosynthesis platform technologies to develop novel therapeutics for the treatment of diseases with high unmet medical needs. The Company previously went by the name Cannabis Technologies, Inc. It changed its name to InMed Pharmaceuticals, Inc. in October of 2014. InMed has its corporate headquarters in Vancouver, British Columbia.

A preclinical stage biopharmaceutical business, InMed Pharmaceuticals specializes in the research and development (R&D) of novel, cannabinoid-based prescription drug therapies employing novel drug delivery systems. The Company conducts research, discovery, preclinical, regulatory, manufacturing and commercial development activities for its product candidates.

InMed Pharmaceuticals is presently developing pre-clinical product candidates. These comprise INM-750 for the treatment of Epidermolysis bullosa; INM-085 for the treatment of glaucoma; and INM-405 for the treatment of pain.

The Company’s lead product, INM-750 has numerous mechanisms-of-action in the skin to deliver symptomatic relief. These include accelerated wound healing, pain reduction, itch reduction, inflammation reduction, and also antimicrobial activity.

InMed’s INM-085 has a proprietary deliver system. INM-085 uses a one x per day hydrogel formulation. This is to address the major issues of non-compliance (dosing frequency, side effects and adherence). The Company’s INM-405 is centered on local administration for Peripheral Pain Management. INM-405 for Pain is targeting topical administration.

In March, InMed Pharmaceuticals announced the publication of a peer-reviewed article in Drug Delivery and Translational Research. The article, titled "A stimulus-responsive, in situ forming, nanoparticle-laden hydrogel for ocular drug delivery", presents results from a pre-clinical study co-sponsored by InMed. The article was co-authored by Dr. Sazzad Hossain, InMed Pharmaceuticals’ Chief Scientific Officer.

The Company originally announced completion of this study in October of last year. These proprietary data support what InMed believes to be a first-in-class nanoparticle-hydrogel formulation for cannabinoid delivery to the eye, resulting in enhanced drug uptake through the cornea and lens. The patent family for this discovery is now at the provisional stage. It will be converted to a PCT filing during this year.

InMed Pharmaceuticals is using its proprietary bioinformatics assessment tool to identify bioactive compounds in the cannabis plant, which have the potential to have physiological impacts on specific diseases. The objective is to identify new drug candidates that optimize therapeutic benefit while limiting adverse effects.

InMed Pharmaceuticals, Inc. (IMLFF), closed Friday's trading session at $0.9854, down 2.43%, on 189,073 volume with 181 trades. The average volume for the last 60 days is 887,097 and the stock's 52-week low/high is $0.177/$1.95.

Rise Gold Corp. (RYES)

StockChase, MarketWatch, Marketwired, Stockhouse, 4-Traders, OTC Markets, and Streetwise Reports reported on Rise Gold Corp. (RYES), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Rise Gold Corp. is an exploration-stage mining company listed on the OTC Markets Group’s OTCQB. The Company’s main asset is the historic past producing Idaho-Maryland Gold Mine located in the State of California. The Idaho-Maryland Mine was a significant past producer, yielding 2.4M oz of gold. Rise Gold has its head office in Vancouver, British Columbia.

There are manifold exploration targets today on the Idaho-Maryland Gold Mine property that is fully owned by Rise Gold. This includes surface and mineral rights. The Company owns all the mineral rights and there are no royalties on this private land. This Mine is near Grass Valley, California.

The Idaho-Maryland Gold Mine produced a total of 2,414,000 oz gold with an average mill head grade of 0.50oz/ton (approximately 17g/t). The Mine was producing up to 129,000 oz gold annually before being forced to shut down by the U.S. government in 1942. During WW II the U.S. War effort wanted to shut down precious metals excavation and shift the national mining workforce from gold to copper production.

This past September, Rise Gold announced that it negotiated an extension of the remaining payment due for the purchase of the 82-acre parcel of M-1 Industrial land neighboring the historic New Brunswick mine shaft in Nevada County, California. The extension of the payment terms will allow Rise Gold to center its financial resources on the exploration drill program at the Idaho-Maryland Gold Project.

The Mill Site property is directly adjacent to the Brunswick Mine shaft. This is where Rise Gold currently owns 37 acres of surface land. The Company’s belief is that the land purchase is a valuable addition to the Idaho-Maryland Gold Project.

In October, Rise Gold announced that exploration core drilling from surface began at the Idaho-Maryland Gold Project in Nevada County, California. The initial exploration drill hole was collared and cased to bedrock. Moreover, the rock core is now being logged.

The initial drill hole will drill through the Brunswick "Porphyrite" Block. It ends in the surrounding serpentinite that hosts the Idaho mineralization. The expectation is that the first hole will pierce several Brunswick style gold-quartz veins and stock-work zones.

Rise Gold Corp. (RYES), closed Friday's trading session at $0.10, up 3.09%, on 92,000 volume with 10 trades. The average volume for the last 60 days is 66,095 and the stock's 52-week low/high is $0.0699/$0.2688.

The QualityStocks Company Corner

Global Payout, Inc. (GOHE)

The QualityStocks Daily Newsletter would like to spotlight Global Payout, Inc. (GOHE).

CannabisNewsAudio announces the Audio Press Release (APR) titled "Budding Legal Cannabis Industry Offers Opportunity Amid Challenge, Chaos," featuring Global Payout, Inc. (OTC Pink: GOHE). To hear the CannabisNewsAudio version, visit To read the original editorial, visit

Global Payout, Inc. (GOHE) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships.

Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout’s fully configurable “banking-in-a-box” web-based platform that can fulfill the front-to-back office processing requirements of domestic, foreign exchange and international payment service providers. This platform is designed to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

The Global Reserve Platform can manage practically any financial product, including core and traditional banking products, online banking, card management, mobile wallets, merchant payment processing, biometric payments and authentication management, bill payments and P2P payments, international remittances, government benefits management, loans management, FOREX, and SWIFT / ACH / SEPA payments. Powered by the Global Reserve Administrative module, the platform can be customized for enterprises across a multitude of business sectors.

Investment in financial technology (FINTECH) companies has grown dramatically in recent years with the role of today’s banks shrinking and demand for improved financial solutions continuing to rise. As the industry has continued to expand rapidly, Global Payout’s management team has directed its focus on identifying the most promising market sectors with FINTECH needs. The four core areas selected are logistics, small and medium enterprises (SME), banking and travel.

In 2015, Global Payout introduced MoneyTrac Technology Inc. as a majority owned subsidiary to more effectively focus on the development of financial technologies that specifically address many of the challenges that enterprises in a variety of alternative and “high-risk” market sectors are faced with in processing financial transactions. Powered by Virtu Network Solutions, the MoneyTrac Technology platform is one the most configurable and intuitive financial technology platforms available to alternative and “high-risk” enterprises and provides them with solutions that effectively manages everything from pin debit and virtual currency, to compliance and cash flow logistics.

With the global economy constantly becoming more diversified and connected, Global Payout is well positioned with the technology software solutions its team has developed to address many different needs worldwide. Management has committed itself to exploring and identifying every avenue possible for further establishing itself as a recognized leader in FINTECH solutions.

Global Payout, Inc. (GOHE), closed the day's trading session at $0.0222, up 32.93%, on 35,098,659 volume with 1,015 trades. The average volume for the last 60 days is 11,120,202 and the stock's 52-week low/high is $0.0099/$0.16.

Recent News

Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF)

The QualityStocks Daily Newsletter would like to spotlight Global Hemp Group, Inc. (GBHPF).

Hemp cultivation company Global Hemp Group (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) is set to profit from if the Hemp Farming Act of 2018 passes. To view the full article, visit:

Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTCQB: GBHPF), headquartered in British Columbia, Canada, is a publicly traded company founded in 2014. Global Hemp Group is focused on acquiring and developing a strategic portfolio of like-minded companies that believe in the significant potential of the industrial hemp plant. Global Hemp Group’s focused on attracting joint venture partners across all sectors of the industrial hemp industries with the commitment to improve quality of life by researching, developing and distributing sustainable materials, products and services produced from hemp.

The company’s mission is to build a strategic portfolio of hemp-based companies that operate synergistically to consistently deliver a solid ROI to its shareholders. Global Hemp Group has established the concept of Hemp Agro-Industrial Zone (HAIZ) ( in order to build cooperative mechanisms across industrial sectors with a focus on different parts of the hemp plant. Under the HAIZ strategy, Global Hemp Group brings together capital, farmers and labor in an effort to build a “soil-to-shelf” portfolio of complimentary companies and joint venture partners in the global hemp industry.

Global Hemp Group has chosen to only work with suppliers of high quality, sustainable raw materials and finished products derived from the hemp plant. Among the leading industries utilizing industrial hemp’s exceptional properties is the automotive sector, building materials market, bio-composites, energy-related markets, super-foods, nutritional supplements, nutraceuticals and the cannabinoid markets. Guided by the principal theme of “global environmental stewardship,” Global Hemp Group focuses on the key concepts of sustainability and social responsibility in all its endeavors.

Global Hemp Group’s joint venture with publicly traded Marijuana Company of America on hemp cultivation trials in 2017, designed to develop commercial hemp production on the Acadian peninsula of New Brunswick, Canada, for the first time in 20 years, was a great success. The partners are preparing for the upcoming changes in Canada’s cannabis legislation that will permit cannabinoid extraction from industrial hemp. Farmers have already been recruited to plant a minimum of 125 acres of industrial hemp for the 2018 growing season, with the goal of increasing the acreage under cultivation to 1,000+ acres by year three of the joint project. Global Hemp Group is preparing an application for a processing license to extract cannabidiol (CBD) and other cannabinoids from the upcoming industrial hemp crop. Discussions are also underway with potential processing partners for the extraction of cannabinoids and straw processing for building materials for the upcoming harvest in October 2018, with a longer term plan to establish permanent processing facilities by October 2019.

Global Hemp Group is led by Charles Larsen as its president, CEO and chairman of the board. Larsen’s more than 30 years of experience working in government, public, private and startup companies as an executive manager includes being the founding president of Medical Marijuana, Inc., the first public company in the Cannabis space. Larsen is also a founder and current director of Marijuana Company of America, Inc., and has been actively involved in the cannabis and hemp industry for nearly a decade. Larsen is joined by Curt Huber, who serves as CFO and director. Huber is an independent corporate and financial consultant with more than 25 years of experience in all facets of public companies among many different sectors including mining, oil and gas, and technology.

Also joining the management team as director is Dr. Paul T. Perrault, an agricultural economist trained in cooperative development and in rural development. Perrault’s experience includes years of consulting on rural development projects introducing new crops in several developing countries and strengthening agricultural research organizations, principally in Africa. Jeff Kilpatrick also serves as a director and is currently a program supervisor of Alachua County Department of Court Services in Gainesville, Florida. Kilpatrick, who spent 21 years in the U.S. Coast Guard, is a member of LEAP – Law Enforcement Against Prohibition – and is president elect for the National Association of Pretrial Services Agencies (NAPSA).

Global Hemp Group’s business philosophy is “A healthier future through sustainable business strategies.“

Global Hemp Group, Inc. (GBHPF), closed the day's trading session at $0.103, up 8.42%, on 25,594 volume with 26 trade. The average volume for the last 60 days is 173,472 and the stock's 52-week low/high is $0.0115/$0.316.

Recent News

Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Earth Science Tech (OTC: ETST), an innovative biotech company focused on the cannabidiol (“CBD”), nutraceutical and pharmaceutical fields, is following through on its objective to reach new heights in the alternative medicine market. To view the full article, visit:

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed the day's trading session at $0.96, up 7.87%, on 33,294 volume with 30 trades. The average volume for the last 60 days is 23,426 and the stock's 52-week low/high is $0.324/$1.75.

Recent News

Sunniva, Inc. (CSE: SNN) (OTCQX: SNNVF)

The QualityStocks Daily Newsletter would like to spotlight Sunniva, Inc. (SNNVF).

Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) announced that its subsidiaries in the United States have received the necessary temporary licenses from the State of California to proceed with the construction of the company’s cultivation facilities in Cathedral City, California (

Sunniva, Inc. (CSE: SNN) (OTCQX: SNNVF) is a vertically integrated medical cannabis company operating in the world’s two largest cannabis markets – Canada and California – committed to delivering safe, consistent, high-quality products and services. Sunniva operates through its wholly owned subsidiaries: Sunniva Medical Inc., CP Logistics, LLC, Natural Health Service Ltd., and Full-Scale Distributors, LLC. Sunniva’s vision is to become the lowest cost, highest quality cannabis producer in the markets it serves by building large scale purpose-built cGMP-compliant greenhouses, offering best quality assurance with cannabis products free from pesticides, providing better patient and doctor access to cannabis education, and sourcing better therapeutic delivery devices.

The company is establishing sophisticated distribution channels, including Sunniva’s ownership of Natural Health Services cannabis clinics in Canada with over 95,000 active patients, to purchase the significant quantities of high quality Sunniva-branded and Sunniva private-labeled cannabis products.

Sunniva is an ancient English name which means, “Gift of the Sun.” Sunniva’s team of horticulturists, scientists and engineers is helping to set best practices for the industry, believing that sun-grown, solar-powered cultivation is the most sustainable and cost-effective way to grow high-quality, premium cannabis.

The Sunniva Family includes:

CP Logistics, LLC

Through its subsidiary, CP Logistics LLC, Sunniva is developing Sunniva Campus, a state-of-the-art, purpose-built greenhouse facility in Cathedral City, California. This modern purpose-built, agri-technology greenhouse will adhere to the Current Good Manufacturing Practice (cGMP) regulations that assure proper design, monitoring and control of manufacturing processes and facilities.

Phase 1 of the project includes a fully funded 325,000 square foot greenhouse capable of producing 60,000 kg per year of dry cannabis at capacity with operations commencing Q3 2018. Approximately 30 percent of initial total production will be converted into oils and extracts. Phase 2 is expected to increase the greenhouse by 165,000 square feet and grow production by about 40,000 kg per year.

These uniquely sealed greenhouses are designed to deploy custom, automation assembly line cultivation processes at a large scale. Energy consumption will be reduced while utilizing the energy of the sun and microclimatic controls to provide precise growing conditions. The greenhouse will recirculate air for more efficient climate control, and the company’s Integrated Pest Management System is designed to ensure every plant grown is certified clean and free of all contaminants and pesticides.

Sunniva Medical Inc.

Sunniva Medical Inc. is designing and preparing to break ground on the Sunniva Canada Campus encompassing 700,000 square feet of purpose-built cGMP greenhouse facilities in the Okanagan Valley, British Columbia. The total campus is expected to produce 100,000 kg of premium medical cannabis a year plus additional trim used for extraction. This facility will produce pesticide-free products and will convert trim to extracted products such as cannabis oil that can be used for drug delivery formats such as capsules, dissolvable strips, vaporization cartridges, tinctures and creams.

Sunniva and Canopy Growth Corporation (“Canopy Growth”) recently announced a large take or pay supply agreement. Under the terms of the agreement, Canopy Growth will purchase up to 45,000 kilograms of dried cannabis annually commencing Q1 2019, which includes the distribution of Sunniva branded products. Sunniva Medical is a late-stage applicant under Canada’s ACMPR and is in the final review stage of the process.

Natural Health Services Ltd.

Natural Health Services (“NHS”) owns and operates a network of eight medical clinics in Canada specializing in medical cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”). NHS connects licensed producers to their 21 physicians and patients with its proprietary SPARK software which utilizes a software-as-a-service revenue model. To date, there are 27 integrated licensed producers utilizing the SPARK software.

In-house physicians specializing in the endocannabinoid system provide expert consultation, education and recommendations for targeted phytoceutical remedies and wellness plans to improve the quality of life for all patients. NHS enjoys a long-term relationship with patients due to the quality of its physician-patient experience. A rapidly expanding NHS cannabis clinic network serves 94,000 active patients in Canada. NHS has also initiated a pilot program with a national pharmacy chain to aggregate more patients.

Full-Scale Distributors, LLC

Full-Scale Distributors, LLC is an industry leading provider of custom, private-label vaporizers through its brand, Vapor Connoisseur. The company currently serves the needs of over 80 top brands in the North American marketplace. Vapor Connoisseur is recognized for its high quality and innovative therapeutic delivery devices. Products are tailored to client needs, ensuring both safety and reliability.

Sunniva’s highly experienced management team is building partnerships with leading scientists, universities and clinical trial groups to deliver proprietary cannabis formulations to a broad spectrum of health ailments and conditions. These global partners require cGMP-certified facilities for the processing and manufacturing of cannabis products. Sunniva is committed to providing safe, pesticide-free, high quality, reproducible cannabis medicines.

Leading Sunniva is co-founder, chairman and CEO Dr. Anthony (Tony) Holler. He is the former CEO and founder of ID Biomedical, which was acquired in 2005 for $1.7 billion by GlaxoSmithKline. He is also the former chairman of Corriente Resources Inc., which was sold for approximately $700 million to CRCC-Tongguan Investment Co. Holler is currently chairman of CRH Medical Corporation, a public company trading on the TSX and NYSE. His expertise includes strategic planning, mergers and acquisitions and financing with a singular focus on increasing shareholder value.

Holler is joined by co-founder Leith Pedersen, who serves as president of Sunniva. Pedersen is the former owner and CEO of Vida Wealth Management Bahamas and was a former investment advisor at Canaccord Wealth Management. He is a former partner and director at JF Mackie and Company, an independent brokerage firm in Calgary, Alberta, that managed capital in excess of $2 billion for high net worth clients. Pedersen’s expertise is in corporate strategy, financing and mergers and acquisitions.

Sunniva, Inc. (SNNVF), closed the day's trading session at $6.64, up 1.68%, on 45,552 volume with 156 trades. The average volume for the last 60 days is 39,226 and the stock's 52-week low/high is $6.035/$16.00.

Recent News

Consorteum Holdings, Inc. (CSRH)

The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH).

Software development and mobile solutions company Consorteum Holdings (OTC: CSRH) recently said that its wholly owned subsidiary, 359 Mobile Inc., entered an exclusive joint business agreement with DevLex Ltd. to bring real-time analytic solutions and support to 359’s Universal Mobile Interface (“UMI”) platform. To view the full article, visit:

Consorteum Holdings, Inc. (CSRH) is a software development and mobile solutions company focused on the delivery of digital offerings to mobile devices. The company provides mobile offerings, delivery of mobile content, mobile payments solutions and products through a mix of direct offerings, partnerships, license agreements and joint venture arrangements. A multi-year transition from a transaction management company focused on transaction processing solutions and products for the payment processing and financial transaction markets to multiple business verticals deepens the company’s commitment to deliver innovating solutions to end users who are using smart handset devices in radical new ways.

Consorteum Holdings, utilizing its Universal Mobile Interface™ (“UMI”) solution, offers opportunities in numerous markets with its capacity to support fully regulated, regionally compliant financial and social transactions via web and mobile. The company’s UMI technology has the capacity to provide solutions in FinTech, data analytics, secure payment processing, compliance lead transaction management and various digital social event sectors. The UMI platform allows cross operating system development to support all mobile devices while addressing the complex and highly regulated needs of the mobile FinTech industry.

Led by the development team at Consorteum’s wholly owned subsidiary 359 Mobile Inc., the Company has created an end-to-end FinTech solution utilizing the company’s UMI technology platform. Current mobile application and transaction solutions are plagued by poor experiences. Because UMI’s technology platform is designed to work across innovative payment, experience and product solutions, 359 Mobile believes there are both direct and partnership opportunities for the 359 Mobile UMI solution.

Consorteum’s primary sales and marketing strategy is focused on enabling and delivering solutions to the global mobile FinTech market with an emphasis initially on mobile gaming. The trend towards increased mobile gambling supports the need for a mobile platform such as the UMI to meet existing and new compliance regulations for the online gambling industry. The online gambling market is projected to double to nearly $1 trillion by 2021, according to a study by Juniper Research, with the majority of growth in this sector attributed to mobile devices. Consorteum’s management team believes there are fresh opportunities in this sector such as Mobile Marketing Services providing one-to-one marketing experiences for consumers; offering real-time services to Mobile Sports Book operators; and providing fixed odds betting solutions as well as social-based transactional solutions.

Consorteum’s management team includes Chairman and CEO Craig A. Fielding, a co-founder of the company with extensive experience in technology, programming and large system building; and Chief Operating Officer Patrick Shuster, who has over 25 years of business experience in sales, engineering, operations and marketing for the telecommunications industry. They are joined by John Osborne, SVP of Technology of ThreeFiftyNine Inc., an innovator in embedded systems hardware and software design; Patrick Doran, SVP of business development and marketing with over 30 years of diversified experience in major corporations as well as early stage companies; and Glenn Charlesworth, VP of Accounting, a seasoned executive with a solid track record in financial reporting, strategic planning, general management and operations, finance, start-up situations, and cash flow challenged operations.

Consorteum Holdings is committed to bridging the mobile divide by providing mobile connectivity, secure transactional processing and social connectivity solutions for both cloud and hosted based offerings in multiple business sectors.

Consorteum Holdings, Inc. (CSRH), closed the day's trading session at $0.0007, even for the day, on 872,857 volume with 6 trades. The average volume for the last 60 days is 6,832,875 and the stock's 52-week low/high is $0.0005/$0.0085.

Recent News (CIIX)

The QualityStocks Daily Newsletter would like to spotlight (CIIX)., Inc. (OTCQB: CIIX) projects that its annual sales for the coming fiscal year will double or triple, driven by its diverse cryptocurrency activities and increased advertising revenue from crypto blockchain firms, as CEO Warren Wang noted on the Investor Town Hall Show ( Also today, NetworkNewsWire released a report on the company detailing how CIIX recently acquired equipment to participate in cryptocurrency mining to capitalize on the growing blockchain industry. To view the full article, visit:

Founded in 1999, (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website,, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site,, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. (CIIX), closed the day's trading session at $0.49, even for the day, on 28,217 volume with 17 trades. The average volume for the last 60 days is 65,597 and the stock's 52-week low/high is $0.40/$1.58.

Recent News

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

Specialized holding company SinglePoint, Inc. (OTCQB: SING) was a featured company this week on an episode of MoneyTV with Donald Baillargeon, an internationally syndicated television program discussing “money and what makes it happen.” To view the full interview, visit: To view the full press release, visit:

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.0343, off by 0.29%, on 10,642,739 volume with 446 trades. The average volume for the last 60 days is 8,520,765 and the stock's 52-week low/high is $0.0132/$0.415.

Recent News

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

NetworkNewsWire (“NNW”), a multifaceted financial news and publishing company for business, today announces the audio version of the Lexaria Bioscience Corp. (CSE:LXX) (OTCQX:LXRP) recent press release titled “Lexaria Achieves Significant Breakthrough in Alternative Nicotine Delivery Technology.” To hear the Lexaria AudioPressRelease (APR) version, visit: To read the original press release, visit:

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body’s gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria’s products and others on the market is the company’s disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the “unusual” taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria’s processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company’s patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria’s lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world’s most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed the day's trading session at $1.249, off by 0.68%, on 130,687 volume with 250 trades. The average volume for the last 60 days is 237,732 and the stock's 52-week low/high is $0.27/$2.54.

Recent News

Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF)

The QualityStocks Daily Newsletter would like to spotlight Choom Holdings Inc. (CHOOF).

NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Choom Holdings Inc. (CSE:CHOO) (OTCQB:CHOOF), a client of NNW focused on channeling the spirit of Hawaii in the Okanagan and building culture around its high-grade handcrafted cannabis brand. To view the full publication, titled “Canadian Cannabis Growers Focus on Scaling Production,” visit:

Choom Holdings Inc. (OTCQB: CHOOF) (CSE: CHOO) channels the laid-back spirit of Hawaii to the Okanagan region of British Columbia with a generous nod to the inspirational, yet unofficial, history of the 1970s “Choom Gang,” a group of buddies in Honolulu (including former President Barack Obama) who knew how to relax with “choom,” the local’s term for marijuana. Choom’s trademark slogans pivot off another unconventional phrase (“Say Hello to…”), bringing a heady dose of good times and good friends together as the company invites investors to “Say Hello to Choom™” as it lights up the adult recreational cannabis market in Canada.

Choom™ has been an ACMPR (Access to Cannabis for Medical Purposes Regulations) applicant since November 2013 in Vernon, B.C. The company’s first application has received security clearance and is now in the detailed review stage. They also recently announced their second late-stage ACMPR application, which is in its confirmation of readiness stage. Cannabis Compliance Inc. has been retained to help expedite Choom’s initial license applications to ensure the company’s readiness for legalization of recreational marijuana in Canada mid-summer 2018.

True to the company’s character, Choom™ is retrofitting two large facilities – No. 1 in Vernon, B.C., and No. 2 on Vancouver Island – to house its cannabis growing facilities. Phase 1 of the Vernon property will provide Choom™ with 6,800 square feet of growing space, capable of producing 660 kg/year of cannabis at an estimated revenue of $6.6 million, excluding oils. The company expects this facility to be completed by July 2018, the same month that Canada is expected to formally legalize recreational marijuana for adult use. A potential Phase 2, to be completed by the end of 2018, would add another 6,800 square feet for a total of 1,500 kg/year capacity, which would nearly double No. 1’s revenue. A Level 9 vault is also planned with a storage capacity of 15,000 kg. While the No. 2 facility on Vancouver Island is smaller – 4,500 square feet – its retrofit is also slated to be completed by July 2018. Plans include doubling this space as well, which would add about $9 million in annual revenue, excluding cannabis oils.

Choom™ announced its retail dispensary strategy with the intention of establishing market leadership in reaching the Canadian cannabis consumer. The partner program is already in the retail space design stage as the company seeks to build a chain of branded retail cannabis dispensaries in jurisdictions in Canada where recreational cannabis is legal. Choom™ Stores will have a cool, modern layout and design created to emit an authentic “Aloha” vibe. Choom™ is all about producing high-grade cultivars and curating them for a bigger audience.

A savvy, experienced management team includes Chris Bogart, president and CEO; John Oh, R.P.I.C., Operations Manager; Robert Bayrack, Master Grower, S.P.I.C.; and Adrian Robinson, Strategic Advisor. Bogart has over two decades of international experience in capital markets and was a co-founder of InMed Pharmaceuticals and Magnum Uranium. He has structured complex equity financing transactions in the U.S., Europe and Canada. Bogart is joined on the Board of Directors by Kevin Pull, Stephen Tong and John Oh.

While the medical marijuana industry is expected to double by 2021 to 500,000 registered users, the true highlight of the recreational cannabis represents the key cultural shift set to launch in Canada. With an estimated $4.9B to $8.7B retail market coming, now is the right time for a Recreation Brand like Choom™ to be involved in this growing industry. Establishing and maintaining Choom™ premium brand loyalty is a key factor in the company’s growth strategy. Get ready to “Say Hello” to opportunity, good times and good friends with Choom™.

Choom Holdings Inc. (CHOOF), closed the day's trading session at $0.715, off by 2.28%, on 133,902 volume with 156 trades. The average volume for the last 60 days is 123,353 and the stock's 52-week low/high is $0.125/$0.8612.

Recent News

AnalytixInsight Inc. (TSX.V: ALY) (OTCQB: ATIXF)

The QualityStocks Daily Newsletter would like to spotlight AnalytixInsight Inc. (ATIXF).

Artificial Intelligence company AnalytixInsight Inc. (TSX-V: ALY; OTCQB: ATIXF) will present at the Planet MicroCap Showcase at 1:30pm (PST) on Wednesday, April 25, 2018 and will conduct 1on1 meetings on April 26, 2018.

AnalytixInsight Inc. (TSX.V: ALY) (OTCQB: ATIXF) is an artificial intelligence (AI) company that transforms data into knowledge. The company has developed a proprietary, machine-learning technology that algorithmically analyzes big data and distills it into actionable insights. AnalytixInsight has strategic initiatives in fintech, blockchain and workflow analytics, and its technology is scalable and extendable to virtually any data-driven industry such as sports, communications, healthcare, insurance or government.

The company’s flagship product – – is a financial portal providing comprehensive company analysis including on-demand fundamental research, portfolio evaluation and screening tools on over 50,000 global equities and North American ETFs. CapitalCube’s online portal is designed to empower investment ideas by providing in-depth analysis, peer-to-peer performance evaluations, accounting and earnings reports, dividend strength and AI-supported information about likely corporate actions such as dividend changes, share buybacks and acquisitions. AnalytixInsight provides a robust technology that is frequently rebalanced to maintain a desired risk profile, matching risk to ideal ETF exposure, with regular compliance reporting.

CapitalCube’s freemium pricing model allows free access to basic financial information, with additional in-depth analysis and predictive analytics provided at a rate of $25 per month, and customized peer analysis for $300 per month. CapitalCube publishes 3,000 articles daily and has multi-language capabilities. Thomson Reuters and Africa Investor have recently been added to the growing network of content partnerships that already includes Euronext NV, Yahoo Finance and The Wall Street Journal.

Euclides Technologies is a subsidiary company focused on Field Service Management software solutions, led by a team with decades of experience in developing and implementing workforce management solutions for large global corporations. With worldwide customers representing over 100,000 field service personnel across multiple industries, Euclides Technologies has a deep understanding of the increasing amount of data generated within the industry, as well as the analytics solution offerings to transform that data into knowledge.

MarketWall is a Fintech subsidiary that develops integrated software solutions as part of an ecosystem of smart devices that includes PCs, tablets, smart phones, wearable mobile devices and Smart TV. AnalytixInsight Inc. has joint ownership in MarketWall together with Intesa Sanpaolo, Italy’s largest retail bank which has over 4,000 branches and a market capitalization of $40 billion Euros. MarketWall is expected to deploy its real-time stock trading and mobile banking app to Intesa Sanpaolo’s 12.6 million customers in six European countries during 2018. The mobile stock trading application will directly interface with Intesa Sanpaolo’s established MarketHub trading platform. As a Samsung Global Partner, the MarketWall app is preloaded in mobile devices in certain areas in Europe.

AnalytixInsight is currently evaluating and pursuing Blockchain initiatives which are contiguous with its artificial intelligence platform, to use a distributed ledger technology to reduce transaction costs and settlement times for its users, partners, and subsidiaries. The Company believes these initiatives will enhance current revenues being received from existing multi-year agreements with its partners.

AnalytixInsight Inc. (ATIXF), closed the day's trading session at $0.3102, off by 2.39%, on 800 volume with 1 trade. The average volume for the last 60 days is 8,177 and the stock's 52-week low/high is $0.15/$0.6898.

Recent News

Zenergy Brands, Inc. (ZNGY)

The QualityStocks Daily Newsletter would like to spotlight Zenergy Brands, Inc. (ZNGY).

Zenergy Brands (OTCQB: ZNGY) is a well-positioned company in a tech savvy market that is favoring energy efficient devices in an effort to reduce carbon footprint while saving money. To view the full article, visit:

Zenergy Brands, Inc. (ZNGY) is the nation’s leading next-generation energy and technology company operating in the emerging smart energy, conservation, and utility industries. Headquartered in Texas, Zenergy provides an entire suite of conservation-based products and services that enable clients to achieve sustainability goals, reduce carbon emissions and improve their bottom line. The company’s cutting-edge Zero Cost Program™ reduces utility expenses by 20 percent to 60 percent by offering energy conservation, smart controls, and efficiency-based products and services to residential, commercial, industrial and municipal end-use customers.

The Zero Cost Program™ is a financing mechanism that allows customers to reduce water, natural gas and electricity expenses by implementing proven conservation technologies at no out-of-pocket cost. The Zero Cost Program™ enriches businesses by immediately reducing energy consumption through the use of smart controls, building automation, LED lighting solutions, refrigeration optimization, efficient water systems, EC motor controls, demand-side management and load factor correction.

A unique Managed Energy Services Agreement (“MESA”) allows a portion of these utility savings to be retained by Zenergy’s partner financing the upgraded, retrofit equipment and installation costs until a specified repayment period ends. After that, clients reap all the financial rewards of the technologies implemented, which Zenergy estimates should range between 25 percent and 45 percent of total utility costs.

Residential customers seeking cost-effective energy savings can also choose from a suite of “Smart Home” products including home automation, security monitoring, and energy conservation services that can be controlled 24/7 from the comfort and convenience of their smartphones or internet-connected smart devices. Zenergy’s residential program offers partnership opportunities for homebuilders and residential, multi-family real estate developers to provide smart home technologies to high-end customers.

Zenergy Brands’ acquisition of Enertrade Electric LLC, a fully operating, licensed Texas-based Retail Electric Provider (REP), further increases the company’s value proposition. Zenergy CEO Alex Rodriguez said this new subsidiary adds an essential complementary service to the company’s suite of smart energy products and services.

“Since our founding, our vision has been to converge smart controls (home and building automation) with energy conservation and retail energy to deliver the comprehensive smart energy service to customers,” Rodriguez said.

On a global scale, residential and commercial buildings account for nearly 45 percent of the world’s total energy consumption. Improving the energy efficiency of these homes and buildings is often a more affordable way to reduce harmful gas emissions while minimizing the need for new energy production. According to Navigant Research, global revenue for energy-efficient commercial building retrofits alone is expected to grow from $71.4 billion in 2016 to $100.8 billion in 2025. At the same time, the energy-efficient devices market is expected to reach a market size of $908 billion by 2022. Increasing demands for reduction in energy consumption and greenhouse gas emissions along with concerns over climate change are contributing factors driving the market’s overall growth.

Zenergy Brands, Inc. (ZNGY), closed the day's trading session at $0.0087, off by 12.12%, on 1,154,428 volume with 34 trades. The average volume for the last 60 days is 3,103,736 and the stock's 52-week low/high is $0.0027/$0.045.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.